Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHSCX vs. XLV: which is better?

Bottom line

SHSCX vs XLV: the short answer

SHSCX (Blackrock Health Sciences Opportunities Portfolio) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But SHSCX is far broader, holding 155 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 1.9% — a difference of $182 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +4.8% for SHSCX.

Updated Nov 19, 2026

SHSCX vs XLV side by side

SHSCXXLV
TypeMutual fundETF
Fund familyBlackRockSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.9%0.08%
Annual cost per $10k$190$8
10-yr cost on $10k (prospectus)$2,016$103
Max front load0%None
12b-1 fee1%0.02%
1-yr return+14.1%+14.5%
5-yr return (annualized)+4.8%+8.1%
10-yr return (annualized)+8.9%+9.8%
Best quarter—+14.5%
Worst quarter—−12.7%
Net assets (fund)$5.9B$40.6B
Number of holdings15565
Portfolio turnover49%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of SHSCX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingSHSCXXLV
Eli Lilly & Company12.29%16.51%
Johnson & Johnson8.77%10.64%
Unitedhealth Group Inc6.10%6.57%
Merck & Company Inc4.94%5.52%
Gilead Sciences Inc4.19%2.73%
Abbvie Inc3.94%7.74%
Amgen Inc3.37%3.40%
Thermo Fisher Scientific Inc3.02%3.24%
Vertex Pharmaceuticals Inc2.74%2.19%
Pfizer Inc2.61%2.39%
Danaher Corp2.00%2.09%
Abbott Laboratories1.97%2.75%
Intuitive Surgical Inc1.95%2.45%
Boston Scientific Corp1.59%1.10%
Elevance Health Inc1.56%1.46%

Source: SEC Form N-PORT

SHSCX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between SHSCX and XLV?
SHSCX (Blackrock Health Sciences Opportunities Portfolio) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But SHSCX is far broader, holding 155 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, SHSCX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both SHSCX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.